We expect tofinish theMino-Loktrial this yearHemorrhoidsis a $2BmarketOnly biotechwith 2 Myron'son theleadershipteamMino-Lokpotentialmarket>$1BI/Ontak isour leadassetNot manycompaniesthis size with2 late stageassetsWe haveenough cashto go wellinto 2023We had aphase 2btrial with100%efficacyMino-WrapMyron Holubiakand I founded aprivatecompany in2013Insidersinvested$26.5mAn actualiMSCupdateI'm ashareholdermyselfThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We intendto submita BLA in2H 2022I/ONTAK'spotentialmarket is>$300mWe willhaveexclusivityI won't diluteshareholdersI/ONTAKwas thebest deal Iever madeThere are noFDAapproveddrugs to treathemorrhoidsMino-Lokis our leadassetOur Halo-Lido trial willhave finalpatient byend of 2022We will openupinternationalsites forMino-Lok trialWe expect tofinish theMino-Loktrial this yearHemorrhoidsis a $2BmarketOnly biotechwith 2 Myron'son theleadershipteamMino-Lokpotentialmarket>$1BI/Ontak isour leadassetNot manycompaniesthis size with2 late stageassetsWe haveenough cashto go wellinto 2023We had aphase 2btrial with100%efficacyMino-WrapMyron Holubiakand I founded aprivatecompany in2013Insidersinvested$26.5mAn actualiMSCupdateI'm ashareholdermyselfThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We intendto submita BLA in2H 2022I/ONTAK'spotentialmarket is>$300mWe willhaveexclusivityI won't diluteshareholdersI/ONTAKwas thebest deal Iever madeThere are noFDAapproveddrugs to treathemorrhoidsMino-Lokis our leadassetOur Halo-Lido trial willhave finalpatient byend of 2022We will openupinternationalsites forMino-Lok trial

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
B
2
O
3
G
4
G
5
G
6
I
7
O
8
N
9
N
10
O
11
B
12
B
13
G
14
O
15
N
16
O
17
N
18
I
19
G
20
I
21
I
22
I
23
B
24
B
  1. B-We expect to finish the Mino-Lok trial this year
  2. O-Hemorrhoids is a $2B market
  3. G-Only biotech with 2 Myron's on the leadership team
  4. G-Mino-Lok potential market >$1B
  5. G-I/Ontak is our lead asset
  6. I-Not many companies this size with 2 late stage assets
  7. O-We have enough cash to go well into 2023
  8. N-We had a phase 2b trial with 100% efficacy
  9. N-Mino-Wrap
  10. O-Myron Holubiak and I founded a private company in 2013
  11. B-Insiders invested $26.5m
  12. B-An actual iMSC update
  13. G-I'm a shareholder myself
  14. O-The name Citius comes from the Olympic motto "Citius,Altius Forius"
  15. N-I/ONTAK was previously approved but taken off the market to improve manufacturing.
  16. O-We intend to submit a BLA in 2H 2022
  17. N-I/ONTAK's potential market is >$300m
  18. I-We will have exclusivity
  19. G-I won't dilute shareholders
  20. I-I/ONTAK was the best deal I ever made
  21. I-There are no FDA approved drugs to treat hemorrhoids
  22. I-Mino-Lok is our lead asset
  23. B-Our Halo-Lido trial will have final patient by end of 2022
  24. B-We will open up international sites for Mino-Lok trial